Latest Asx News

BPH Global reported a seasonal dip in December revenue due to rainy conditions affecting seaweed supply, yet maintains strong growth momentum with A$1.77 million gross revenue over seven months.

Ainsworth Game Technology has issued a Target's Statement responding to an unsolicited proportional takeover bid by Kjerulf David Hastings Ainsworth amid an ongoing full takeover offer from Novomatic. The Independent Board Committee refrains from recommending acceptance or rejection, highlighting complex shareholder choices.

Sprintex Limited has confirmed a significant €15.6 million purchase order from Mest Water, ensuring timely disclosure and compliance with ASX continuous disclosure rules. The company detailed its prior communications and trading halt strategy surrounding the announcement.

West Coast Silver Limited has raised $3.2 million through a strategic placement to fund its 2026 exploration program at the high-grade Elizabeth Hill Silver Project, aiming to unlock further silver mineralisation in the region.

Renergen Limited’s shares will be suspended from ASX trading on December 31, 2025, marking a key step in its acquisition by ASP Isotopes Inc. This suspension follows the formal implementation of a scheme of arrangement agreed earlier this month.

Robex Resources shareholders have overwhelmingly approved a merger with Predictive Discovery, setting the stage for a leading gold producer in West Africa with combined annual output projected to exceed 400,000 ounces by 2029.

Global X Management (AUS) Limited has released updated estimated distribution amounts for over 30 ETFs listed on the ASX AQUA Market for the period ending 31 December 2025, alongside key dates for investors to note.

Betashares Capital Ltd has released estimated distribution amounts for over 70 ETFs for the December 2025 period, highlighting income opportunities across a broad spectrum of funds. Investors should note key dates and the operation of the Distribution Reinvestment Plan.

Memphasys Limited has extended the repayment terms of its convertible notes with major shareholder Peters Investments to mid-2026, reinforcing financial flexibility amid ongoing commercial progress.

Coda Minerals has clarified that its recent share price and volume spike is driven by rising copper and silver prices, with no undisclosed company information influencing the market.

Toro Energy has secured a crucial Foreign Investment Review Board approval for its acquisition by IsoEnergy, moving the deal closer to completion. Shareholder and court approvals remain as the next steps.

Arovella Therapeutics has taken a significant step forward by submitting an IND application to the U.S. FDA for its lead CAR-iNKT cell therapy, ALA-101, targeting blood cancers. This milestone paves the way for a first-in-human Phase 1 trial in both Australia and the U.S.